Rockefeller Capital Management
BBNX

Rockefeller Capital Management’s Beta Bionics BBNX Stock Holding History

Rockefeller Capital Management’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.4K Buy
1,305
+632
+94% +$7.52K ﹤0.01% 3725
2026
Q1 		$6.74K Buy
673
+630
+1,465% +$9.32K ﹤0.01% 4146
2025
Q4 		$1.31K Buy
+43
New +$1.15K ﹤0.01% 4406

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Rockefeller Capital Management's BBNX Position: Q2 2026 in Review

Rockefeller Capital Management increased its Beta Bionics (BBNX) stake by 94% in Q2 2026, buying an estimated $7.52K and bringing the position to 1,305 shares worth $20.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3725.

Rockefeller Capital Management first reported a position in BBNX in Q4 2025 and has held it in 3 quarters since. 133 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • Rockefeller Capital Management held 1,305 shares of Beta Bionics worth $20.4K as of Q2 2026.
  • Rockefeller Capital Management bought 632 Beta Bionics shares in Q2 2026, an estimated $7.52K.
  • Beta Bionics made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #3725 holding.
  • Rockefeller Capital Management first reported a position in Beta Bionics in Q4 2025 and has held it in 3 quarters since.
  • 133 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.